ClinicalTrials.Veeva

Menu

Technologies to Improve QoL of Prostate Cancer (MIO)

F

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Status

Not yet enrolling

Conditions

Prostate Cancer

Treatments

Device: Mobile App M.I.O

Study type

Interventional

Funder types

Other

Identifiers

NCT06516276
2023/38PI

Details and patient eligibility

About

The M.I.O Project, which stands for Comprehensive Oncological Medicine, aims to comprehensively and multidisciplinary address the effects of prostate cancer, specifically in patients with hormone-sensitive metastatic prostate cancer (HSMPC), an advanced stage of the disease that still offers prolonged survival due to new medications. The proposal seeks to develop a healthcare approach that promotes self-care and improves the physical and mental health of patients.

Despite growing scientific evidence supporting an integrative approach in oncological care, the provision of personalized options for exercise, nutrition, and psychological therapy before, during, and after diagnosis remains limited. The project proposes to develop tools such as a dedicated mobile application that provides HSMPC patients access to various resources and therapies to improve their health, focusing on nutrition, exercise, and emotional well-being.

M.I.O represents an innovative and holistic approach to addressing these patients' needs and improving their overall well-being. The main goal is to measure the quality of life of the application users through validated questionnaires in a randomized health education study to assess if there is a substantial improvement in their well-being.

Enrollment

98 estimated patients

Sex

Male

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients histologically diagnosed with prostate cancer
  • Metastases confirmed by validated imaging studies
  • Not meet criteria for castration resistance.

Exclusion criteria

  • Do not have a smartphone device
  • Refuse to participate
  • Not sign the informed consent.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

98 participants in 2 patient groups

MOBILE App
Experimental group
Description:
The intervention group will receive standard nutrition, physical exercise, and emotional care recommendations according to scientific evidence and instructions on using the MIO mobile application.
Treatment:
Device: Mobile App M.I.O
Control Standard Recommendations
No Intervention group
Description:
The control group will receive the same recommendations without additional support tools.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems